Anatomy of a Transcatheter Mitral Valve Service

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2022 May 2

PMID 35497993

Authors

Harminder Gill

Heath S L Adams

Omar Chehab

Christopher Allen

Jane Hancock

Pablo Lamata

Gianluca Lucchese

Bernard Prendergast

Simon Redwood

Tiffany Patterson

Ronak Rajani

Affiliations

Soon will be listed here.

Abstract

Transcatheter mitral therapies offer treatment options to selected patients who are unable to undergo open procedures due to prohibitive surgical risk. Data detailing the design and structure of transcatheter mitral services to ensure appropriate patient selection and tailored management strategies is lacking. We report our initial experience of developing and running a purpose-built transcatheter mitral service. The nature and number of referral sources, the multi-disciplinary make-up of the dedicated Mitral Heart Team and the use of integrative imaging assessment with incorporation of computational solutions are discussed. In addition, a summary of the clinical decision-making process is presented. This report sets out a framework from which future clinics can evolve to improve and streamline the delivery of transcatheter mitral therapies.

Citing Articles

The evolution of technical prerequisites and local boundary conditions for optimization of mitral valve interventions-Emphasis on skills development and institutional risk performance.

Cocchieri R, van de Wetering B, Baan Jr J, Driessen A, Riezebos R, van Tuijl S Front Cardiovasc Med. 2023; 10:1101337.

PMID: 37547244 PMC: 10402900. DOI: 10.3389/fcvm.2023.1101337.

References

de Vecchi A, Marlevi D, Nordsletten D, Ntalas I, Leipsic J, Bapat V . Left ventricular outflow obstruction predicts increase in systolic pressure gradients and blood residence time after transcatheter mitral valve replacement. Sci Rep. 2018; 8(1):15540. PMC: 6195528. DOI: 10.1038/s41598-018-33836-7. View

Mack M, Carroll J, Thourani V, Vemulapalli S, Squiers J, Manandhar P . Transcatheter Mitral Valve Therapy in the United States: A Report From the STS-ACC TVT Registry. J Am Coll Cardiol. 2021; 78(23):2326-2353. DOI: 10.1016/j.jacc.2021.07.058. View

Taramasso M, Gavazzoni M, Nickenig G, Maisano F . Transcatheter mitral repair and replacement: which procedure for which patient?. EuroIntervention. 2019; 15(10):867-874. DOI: 10.4244/EIJ-D-19-00743. View

Jones D, Chew D, Horsfall M, Sinhal A, Joseph M, Baker R . Impact of Surgical and Transcatheter Aortic Valve Replacement on Frailty Score. Heart Lung Circ. 2021; 31(4):566-574. DOI: 10.1016/j.hlc.2021.09.014. View

Hahn R, Asch F, Weissman N, Grayburn P, Kar S, Lim S . Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial. J Am Coll Cardiol. 2020; 76(11):1305-1314. DOI: 10.1016/j.jacc.2020.07.035. View

Karady J, Ntalas I, Prendergast B, Blauth C, Niederer S, Maurovich-Horvat P . Transcatheter mitral valve replacement in mitral annulus calcification - "The art of computer simulation". J Cardiovasc Comput Tomogr. 2018; 12(2):153-157. DOI: 10.1016/j.jcct.2017.12.007. View

Wolff G, Shamekhi J, Al-Kassou B, Tabata N, Parco C, Klein K . Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients. Clin Res Cardiol. 2020; 110(3):368-376. PMC: 7907023. DOI: 10.1007/s00392-020-01731-9. View

Mehr M, Karam N, Taramasso M, Ouarrak T, Schneider S, Lurz P . Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe MR and TR: An Analysis From the TriValve and TRAMI Registries. JACC Cardiovasc Interv. 2020; 13(5):543-550. DOI: 10.1016/j.jcin.2019.10.023. View

Keller K, Hobohm L, Schmidtmann I, Munzel T, Baldus S, von Bardeleben R . Centre procedural volume and adverse in-hospital outcomes in patients undergoing percutaneous transvenous edge-to-edge mitral valve repair using MitraClip® in Germany. Eur J Heart Fail. 2021; 23(8):1380-1389. DOI: 10.1002/ejhf.2162. View

10.

Spartera M, Galderisi M, Mele D, Cameli M, DAndrea A, Rossi A . Role of cardiac dyssynchrony and resynchronization therapy in functional mitral regurgitation. Eur Heart J Cardiovasc Imaging. 2016; 17(5):471-80. DOI: 10.1093/ehjci/jev352. View

11.

Compagnone M, Moretti C, Marcelli C, Taglieri N, Ghetti G, Corsini A . Surgical Risk Scores Applied to Transcatheter Aortic Valve Implantation: Friends or Foes? Short-Term and Long-Term Outcomes From a Single-Center Registry. J Invasive Cardiol. 2019; 31(10):E282-E288. View

12.

Coats A, Anker S, Baumbach A, Alfieri O, von Bardeleben R, Bauersachs J . The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA),.... Eur Heart J. 2021; 42(13):1254-1269. PMC: 8014526. DOI: 10.1093/eurheartj/ehab086. View

13.

Kavsur R, Iliadis C, Spieker M, Brachtendorf B, Tiyerili V, Metze C . Predictors and prognostic relevance of tricuspid alterations in patients undergoing transcatheter edge-to-edge mitral valve repair. EuroIntervention. 2021; 17(10):827-834. PMC: 9724950. DOI: 10.4244/EIJ-D-20-01094. View

14.

. Corrigendum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for.... Eur Heart J. 2022; 43(21):2022. DOI: 10.1093/eurheartj/ehac051. View

15.

Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Detaint D, Vanoverschelde J . What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?. Eur Heart J. 2007; 28(11):1358-65. DOI: 10.1093/eurheartj/ehm001. View

16.

Kavsur R, Spieker M, Iliadis C, Metze C, Transier M, Tiyerili V . Mitral Regurgitation International Database (MIDA) Score Predicts Outcome in Patients With Heart Failure Undergoing Transcatheter Edge-to-Edge Mitral Valve Repair. J Am Heart Assoc. 2021; 10(13):e019548. PMC: 8403297. DOI: 10.1161/JAHA.120.019548. View

17.

Besler C, Orban M, Rommel K, Braun D, Patel M, Hagl C . Predictors of Procedural and Clinical Outcomes in Patients With Symptomatic Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair. JACC Cardiovasc Interv. 2018; 11(12):1119-1128. DOI: 10.1016/j.jcin.2018.05.002. View

18.

Chhatriwalla A, Vemulapalli S, Holmes Jr D, Dai D, Li Z, Ailawadi G . Institutional Experience With Transcatheter Mitral Valve Repair and Clinical Outcomes: Insights From the TVT Registry. JACC Cardiovasc Interv. 2019; 12(14):1342-1352. DOI: 10.1016/j.jcin.2019.02.039. View

19.

Peri-Okonny P, Mi X, Khariton Y, Patel K, Thomas L, Fonarow G . Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry. JACC Heart Fail. 2019; 7(4):350-358. PMC: 6440823. DOI: 10.1016/j.jchf.2018.11.011. View